← Leaderboards
David E Housman
Massachusetts Institute Of Technology
$13,337,856
Attributed
$18,233,947
Total exposure
15
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$18,233,947 · 15
By mechanism
R01$7,558,715 · 3
P01$4,691,653 · 6
RC2$2,922,996 · 1
P30$1,451,245 · 3
P50$1,280,447 · 1
U54$328,891 · 1
Top collaborators
- Ernest Fraenkel12 shared
- Leslie Michels Thompson7 shared
- Christopher B Burge2 shared
- Thomas Alexander Cooper2 shared
Others in their field
Top investigators on “Gene Expression”
- Jeffrey P Krischer · University Of South Florida$137,481,663
- Eric S Lander · Whitehead Institute For Biomedical Res$128,154,716
- Stacey Gabriel · Massachusetts Institute Of Technology$86,302,566
- Bruce W Stillman · Cold Spring Harbor Laboratory$82,324,317
- Michael P Snyder · Yale University$75,701,723
- Ronald G Crystal · Weill Medical College Of Cornell Univ$74,774,977
Research focus
Gene ExpressionProgramsPathway InteractionsInsightGenesBaseCellsResponseTherapeutic InterventionPathogenesisLinkBrainAnimalsPathologyDisease ModelGenetic TranscriptionInduced Pluripotent Stem CellLaboratory MouseCell Culture TechniquesNeurodegenerative DisordersEpigenetic ProcessHuntington DiseaseCell TypeMutant
Grant awards (54)
Epigenetic Pathology and Therapy in Huntington's Disease$396,242
R01 · FY2024 · NS
Epigenetic Pathology and Therapy in Huntington's Disease$408,497
R01 · FY2023 · NS
Epigenetic pathology and therapy in Huntington's disease$408,497
R01 · FY2022 · NS
Epigenetic pathology and therapy in Huntington's disease$408,497
R01 · FY2021 · NS
Epigenetic pathology and therapy in Huntington's disease$421,147
R01 · FY2020 · NS
Epigenetic pathology and therapy in Huntington's disease$554,354
R01 · FY2019 · NS
Epigenetic pathology and therapy in Huntington's disease$67,210
R01 · FY2019 · NS
Epigenetic pathology and therapy in Huntington's disease$554,354
R01 · FY2018 · NS
Epigenetic pathology and therapy in Huntington's disease$554,354
R01 · FY2017 · NS
Epigenetic pathology and therapy in Huntington's disease$554,354
R01 · FY2016 · NS
Epigenetic pathology and therapy in Huntington's disease$554,354
R01 · FY2015 · NS
Epigenetic pathology and therapy in Huntington's disease$50,000
R01 · FY2015 · NS
Shared Research Resources$130,956
P30 · FY2014 · CA · contact PI
Shared Research Resources$214,350
P30 · FY2013 · CA · contact PI
Shared Research Resources$134,981
P30 · FY2012 · CA · contact PI
Shared Research Resources$134,968
P30 · FY2011 · CA · contact PI
Deep Sequencing Analysis of mRNA Isoform Expression Changes in Myotonic Dystrophy$1,439,889
RC2 · FY2010 · HG
Shared Research Resources$142,018
P30 · FY2010 · CA · contact PI
Deep Sequencing Analysis of mRNA Isoform Expression Changes in Myotonic Dystrophy$1,483,107
RC2 · FY2009 · HG
CORE--SHARED RESEARCH RESOURCE$266,780
P30 · FY2009 · CA · contact PI
MOUSE MODEL CORE$196,460
U54 · FY2009 · CA · contact PI
GENETICS OF VASOREGULATION AND CARDIOVASCULAR RESPONSES$765,789
P01 · FY2008 · HL · contact PI
CORE--SHARED RESEARCH RESOURCE$266,780
P30 · FY2008 · CA · contact PI
MOUSE MODEL CORE$132,431
U54 · FY2008 · CA · contact PI
GENETICS OF VASOREGULATION AND CARDIOVASCULAR RESPONSES$669,728
P01 · FY2007 · HL · contact PI
CORE--SHARED RESEARCH RESOURCE$160,412
P30 · FY2007 · CA · contact PI
GENETICS OF VASOREGULATION AND CARDIOVASCULAR RESPONSES$680,548
P01 · FY2006 · HL · contact PI
GENETICS OF VASOREGULATION AND CARDIOVASCULAR RESPONSES$660,728
P01 · FY2005 · HL
Molecular pathway to cardiac conduction defects$459,315
P01 · FY2005 · HL
GENETICS OF VASOREGULATION AND CARDIOVASCULAR RESPONSES$672,184
P01 · FY2004 · HL
GENETICS OF CORONARY THROMBOSIS$312,660
R01 · FY2004 · HL
Molecular pathway to cardiac conduction defects$270,475
P01 · FY2004 · HL
GENETICS OF ESTROGEN AND CARDIOVASCULAR RESPONSES$325,671
P50 · FY2003 · HL
GENETICS OF CORONARY THROMBOSIS$312,660
R01 · FY2003 · HL
GENETICS OF ESTROGEN AND CARDIOVASCULAR RESPONSES$316,305
P50 · FY2002 · HL
GENETICS OF CORONARY THROMBOSIS$312,660
R01 · FY2002 · HL
CORE--GENOMICS FACILITY$0
P01 · FY2002 · CA
CORE--MICROARRAY TECHNOLOGIES$0
P30 · FY2002 · CA
Molecular pathway to cardiac conduction defects$0
P01 · FY2002 · HL
GENETIC ANALYSIS OF TUMORIGENESIS, TUMOR PROGRESSION$0
P01 · FY2002 · CA
HIGH THROUGHPUT LOW COST IRS PCR BASED GENOTYPING$532,567
R01 · FY2001 · HG
GENETICS OF CORONARY THROMBOSIS$312,660
R01 · FY2001 · HL
GENETICS OF ESTROGEN AND CARDIOVASCULAR RESPONSES$307,211
P50 · FY2001 · HL
MOLECULAR GENETICS OF WILMS'TUMOR$0
P01 · FY2001 · CA
CORE--MICROARRAY TECHNOLOGIES$0
P30 · FY2001 · CA
Molecular pathway to cardiac conduction defects$0
P01 · FY2001 · HL
CORE--GENOMICS FACILITY$0
P01 · FY2001 · CA
GENETIC ANALYSIS OF TUMORIGENESIS, TUMOR PROGRESSION$0
P01 · FY2001 · CA
HIGH THROUGHPUT LOW COST IRS PCR BASED GENOTYPING$518,225
R01 · FY2000 · HG
GENES RESPONSIBLE FOR PREDISPOSITION TO CARDIOVASCULAR DISEASE$377,596
P01 · FY2000 · HL
GENETICS OF ESTROGEN AND CARDIOVASCULAR RESPONSES$331,260
P50 · FY2000 · HL
GENETICS OF CORONARY THROMBOSIS$325,423
R01 · FY2000 · HL
MOLECULAR GENETICS OF WILMS'TUMOR$135,290
P01 · FY2000 · CA
CORE--MICROARRAY TECHNOLOGIES$0
P30 · FY2000 · CA